共 6 条
[1]
Forney J.P., Buschbaum H.J., Classifying staging and treating uterine sarcomas, Contemporary Ob Gyn, 18, 3, (1981)
[2]
Bergman L., Beelen M.L., Gallee M.P., Hollema H., Benraadt J., Van Leeuwen F.E., Risk and prognosis of endometrial cancer after tamoxifen for breast cancer. Comprehensive Cancer Centres ALERT Group Assessment of Liver and Endometrial Cancer Risk Following Tamoxifen, Lancet, 356, pp. 881-887, (2000)
[3]
Wickerham D.L., Fisher B., Wolmark N., Bryant J., Costantino J., Bernstein L., Runowicz C.D., Association of tamoxifen and uterine sarcoma, J Clin Oncol, 20, pp. 2758-2760, (2002)
[4]
Major F.J., Blessing J.A., Silverberg S.G., Morrow C.P., Creasmam W.T., Currie J.L., Yordan E., Brady M.F., Prognostic factors in early stage uterine sarcoma. A Gynaecologic Oncology group study, Cancer, 71, 4, pp. 1702-1709, (1993)
[5]
Evans H.L., Chawla S.P., Simpson C., Finn K.P., Smooth muscle neoplasms of the uterus other than ordinary leiomyoma. A study of 46 cases, with emphasis on diagnostic criteria and prognostic factors, Cancer, 62, 10, pp. 2239-2247, (1988)
[6]
Piver M.S., Lele S.B., Marchetti D.L., Emrich L.J., Effect of adjuvant chemotherapy on time to recurrence and survival of stage 1 uterine sarcomas, J Surg Oncol, 38, 4, pp. 233-239, (1988)